2008

Brennan, JM and Petersen, JL (2008).
Early intervention: which patients and how early?
Current cardiology reports.

Brilakis, ES, de, Le, Cannon, CP, Wiviott, SD, Murphy, SA, Morrow, DA, Sabatine, MS, Banerjee, S, Blazing, MA, Califf, RM, and Braunwald, E (2008).
Outcomes of Patients With Acute Coronary Syndrome and Previous Coronary Artery Bypass Grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] Trials)
The American journal of cardiology.

Budoff, MJ, Dowe, D, Jollis, JG, Gitter, M, Sutherland, J, Halamert, E, Scherer, M, Bellinger, R, Martin, A, Benton, R, DeLago, A, and Min, JK (2008).
Diagnostic performance of 64-multidetector row coronary computed tomographic angiography for evaluation of coronary artery stenosis in individuals without known coronary artery disease: results from the prospective multicenter ACCURACY (Assessment by Coronary Computed Tomographic Angiography of Individuals Undergoing Invasive Coronary Angiography) trial
Journal of the American College of Cardiology.

Buller, CE, Fu, Y, Mahaffey, KW, Todaro, TG, Adams, P, Westerhout, CM, White, HD, van, 't, Van, de, Wagner, GS, Granger, CB, and Armstrong, PW (2008).
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial
Circulation.

Bushnell, CD, Lee, J, Duncan, PW, Newby, LK, and Goldstein, LB (2008).
Impact of comorbidities on ischemic stroke outcomes in women
Stroke; a journal of cerebral circulation.

Califf, RM (2008).
Review: PCI has lower risk for procedural stroke but higher risks for angina and repeated revascularization than CABG
ACP journal club.

Califf, RM (2008).
The benefits of moving quality to a national level
American heart journal.

Califf, RM and Ginsburg, GS (2008).
Organizational improvements to enhance modern clinical epidemiology
JAMA : the journal of the American Medical Association.

Califf, RM and Kramer, JM (2008).
The balance of benefit and safety of rosiglitazone: important lessons for our system of drug development and postmarketing assessment
Pharmacoepidemiology and drug safety.

Califf, RM, Boolell, M, Haffner, SM, Bethel, MA, McMurray, J, Duggal, A, and Holman, RR (2008).
Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
American heart journal.

Califf, RM, Rasiel, EB, and Schulman, KA (2008).
Considerations of net present value in policy making regarding diagnostic and therapeutic technologies
American heart journal.

Campbell, SJ, Deshmukh, HS, Nelson, CL, Bae, IG, Stryjewski, ME, Federspiel, JJ, Tonthat, GT, Rude, TH, Barriere, SL, Corey, R, and Fowler, VG (2008).
Genotypic Characteristics of Staphylococcus aureus Isolates from a Multinational Trial of Complicated Skin and Skin Structure Infections
Journal of clinical microbiology.

Canlas, KR, Dobozi, BM, Lin, S, Smith, AD, Rockey, DC, Muir, AJ, Agrawal, NM, Poleski, MH, Patel, K, and McHutchison, JG (2008).
Using capsule endoscopy to identify GI tract lesions in cirrhotic patients with portal hypertension and chronic anemia
Journal of clinical gastroenterology.

Cannon, CP, Giugliano, RP, Blazing, MA, Harrington, RA, Peterson, JL, Sisk, CM, Strony, J, Musliner, TA, McCabe, CH, Veltri, E, Braunwald, E, and Califf, RM (2008).
Rationale and design of IMPROVE-IT (IMProved Reduction of Outcomes: Vytorin Efficacy International Trial): comparison of ezetimbe/simvastatin versus simvastatin monotherapy on cardiovascular outcomes in patients with acute coronary syndromes
American heart journal.

Caram, LB, Linefsky, JP, Read, KM, Murdoch, DR, Lalani, T, Woods, CW, Reller, LB, Kanj, SS, Premru, MM, Ryan, S, Al-Hegelan, M, Donnio, PY, Orezzi, C, Paiva, MG, Tribouilloy, C, Watkin, R, Harris, O, Eisen, DP, Corey, GR, Cabell, CH, and Petti, CA (2008).
Leptotrichia endocarditis: Report of two cases from the International Collaboration on Endocarditis (ICE) database and review of previous cases
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.

Carrier, M, Emery, R, Kandzari, DE, Harrington, R, Guertin, MC, and Tardif, JC (2008).
Protective effect of pyridoxal-5-phosphate (MC-1) on perioperative myocardial infarction is independent of aortic cross clamp time: results from the MEND-CABG trial
The Journal of cardiovascular surgery.

Case, LE, Koeberl, DD, Young, SP, Bali, D, Dearmey, SM, Mackey, J, and Kishnani, PS (2008).
Improvement with ongoing Enzyme Replacement Therapy in advanced late-onset Pompe disease: a case study
Molecular genetics and metabolism.

Cavender, MA and Ohman, EM (2008).
What do you need to know before performing a percutaneous coronary intervention?
Circulation.

Cavender, MA, Rao, SV, and Ohman, EM (2008).
Major bleeding: management and risk reduction in acute coronary syndromes
Expert opinion on pharmacotherapy.

Chalasani, N, Fontana, RJ, Bonkovsky, HL, Watkins, PB, Davern, T, Serrano, J, Yang, H, and Rochon, J (2008).
Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States
Gastroenterology.

Chan, MY and Becker, RC (2008).
Identification and treatment of arterial thrombophilia
Current treatment options in cardiovascular medicine.

Chan, MY, Andreotti, F, and Becker, RC (2008).
Hypercoagulable states in cardiovascular disease
Circulation.

Chan, MY, Becker, RC, Harrington, RA, Peterson, ED, Armstrong, PW, White, H, Fox, KA, Ohman, EM, and Roe, MT (2008).
Noninvasive, medical management for non-ST-elevation acute coronary syndromes
American heart journal.

Chan, MY, Cohen, MG, Dyke, CK, Myles, SK, Aberle, LG, Lin, M, Walder, J, Steinhubl, SR, Gilchrist, IC, Kleiman, NS, Vorchheimer, DA, Chronos, N, Melloni, C, Alexander, JH, Harrington, RA, Tonkens, RM, Becker, RC, and Rusconi, CP (2008).
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease
Circulation.

Chan, MY, Mahaffey, KW, Sun, LJ, Pieper, KS, White, HD, Aylward, PE, Ferguson, JJ, Califf, RM, and Roe, MT (2008).
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease
Jacc.